Part of Thermo Fisher Scientific, Inc., T Cell Diagnostics, Inc. is an American company located in Cambridge, MA, that develops blood therapy treatments. Endogen, Inc., a subsidiary of Thermo Fisher Scientific, Inc. since July 1999, acquired T Cell Diagnostics, Inc. from T Cell Sciences, Inc. on March 05, 1996 for $2.90 million.